Evidence map›Paper›PMID 34023473›Full record

Observational studyGastroenterologia y hepatologia2022

Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease.

Engy Refaie, Sandra García Mateo, Samuel Jesús Martínez Domínguez, Carla Jerusalén Gargallo-Puyuelo, Laura Lario Quilez, Patricia Carrera-Lasfuentes, María Teresa Arroyo Villarino, Fernando Gomollón García

Open access · greenAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Gastroenterologia y hepatologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study.Journal of the Formosan Medical Association = Taiwan yi zhi · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Engy RefaieUniversity of Medicine, Milan, Italy.
Sandra García MateoDepartment of Gastroenterology, IBD Unit, University Hospital Lozano Blesa, 50009 Zaragoza, Spain. Electronic address: sgarciamateo7@gmail.com.
Samuel Jesús Martínez DomínguezDepartment of Gastroenterology, IBD Unit, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.
Carla Jerusalén Gargallo-PuyueloDepartment of Gastroenterology, IBD Unit, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.
Laura Lario QuilezDepartment of Gastroenterology, IBD Unit, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.
Patricia Carrera-LasfuentesCIBERehd, 28029 Madrid, Spain.
María Teresa Arroyo VillarinoDepartment of Gastroenterology, IBD Unit, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.
Fernando Gomollón GarcíaDepartment of Gastroenterology, IBD Unit, University Hospital Lozano Blesa, 50009 Zaragoza, Spain; ISS Aragon, 50009 Zaragoza, Spain; Department of Medicine, Psychiatry and Dermatolohy, University of Zaragoza, Spain.
Hospital Clínico Universitario Lozano Blesa · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversidad de Zaragoza · ESUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe lockdown period due to the coronavirus disease 2019 (COVID-19) in Spain probably had a significant emotional impact on chronic patients and hence on those who are suffering from inflammatory bowel disease (IBD) due to their high risk of emotional disorders. The aim of this study was to learn how COVID-19 influenced patients suffering from IBD during the quarantine period, focusing in particular on psychological distress through the Perceived Stress Scale-10 (PSS-10) and also the impact of the pandemic on therapeutic adherence using the Visual Analogue Scale (VAS). PATIENTS AND

methodsA prospective, single-centre and analytical observational study was carried out in the IBD unit in August 2020. Patients were contacted and interviewed by phone. A descriptive analysis was carried out and subsequently the factors associated with the loss of therapeutic adherence and higher-moderate levels of stress were analyzed through logistic regression multivariate analyses.

resultsA total of 426 patients were included with a median PSS-10 score of 12 (10-16). A higher level of stress was reported by those who were not married, women and those who experienced an increase in IBD-related symptoms. Adherence to treatment was not associated with stress based on the PSS-10 questionnaire.

conclusionsAlthough the lockdown period due to the COVID-19 pandemic has probably had a significant emotional impact on Spaniards with IBD, IBD patients in general had lower PSS-10 scores.

Indexed as

Communicable Disease ControlAdultAgedCOVID-19FemaleHumansInflammatory Bowel DiseasesInterviews as TopicMaleMedication AdherenceMiddle AgedProspective StudiesSpainStress, PsychologicalYoung AdultAdherencia terapéuticaEnfermedad inflamatoria intestinalEstrés percibidoInflammatory bowel diseasePerceived stressSARS-CoV-2Therapeutic adherence

Identifiers

PMID34023473
PMCPMC8137343
OpenAlexW3164509203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.